PT  - JOURNAL ARTICLE
AU  - Ahlers, Michael J.
AU  - Aralis, Hilary J.
AU  - Tang, Wilson L.
AU  - Sussman, Jeremy B.
AU  - Fonarow, Gregg C.
AU  - Ziaeian, Boback
TI  - Non-Pharmaceutical Interventions and COVID-19 Burden in the United States
AID  - 10.1101/2021.09.26.21264142
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.26.21264142
4099  - http://medrxiv.org/content/early/2021/09/28/2021.09.26.21264142.1.short
4100  - http://medrxiv.org/content/early/2021/09/28/2021.09.26.21264142.1.full
AB  - Background Non-pharmaceutical interventions (NPIs) are mitigation strategies used to reduce the spread of transmissible diseases. The relative effectiveness of specific NPIs remains uncertain.Methods We used state-level Coronavirus disease 2019 (COVID-19) case and mortality data between January 19, 2020 and March 7, 2021 to model NPI policy effectiveness. Empirically derived breakpoints in case and mortality velocities were used to identify periods of stable, decreasing, or increasing COVID-19 burden. The associations between NPI adoption and subsequent decreases in case or death velocities were estimated using generalized linear models accounting for weekly variability shared across states. State-level NPI policies included: stay at home order, indoor public gathering ban (mild >10 or severe ≤10), indoor restaurant dining ban, and public mask mandate.Results 28,602,830 cases and 511,899 deaths were recorded. The odds of a decrease in COVID-19 case velocity were significantly elevated for stay at home (OR 2.02, 95% CI 1.63-2.52), indoor dining ban (OR 1.62, 95% CI 1.25-2.10), public mask mandate (OR 2.18, 95% CI 1.47-3.23), and severe gathering ban (OR 1.68, 95% CI 1.31-2.16). In mutually adjusted models, odds remained elevated for stay at home (AOR 1.47, 95% CI 1.04-2.07) and public mask mandate (AOR = 2.27, 95% CI 1.51-3.41). Stay at home (OR 2.00, 95% CI 1.53-2.62; AOR 1.89, 95% CI 1.25-2.87) was also associated with greater likelihood of decrease in death velocity in unadjusted and adjusted models.Conclusions NPIs employed in the U.S. during the COVID-19 pandemic, most significantly stay at home orders, were associated with decreased COVID-19 burden.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthors deny receiving payment or services from a third party for any aspect of the submitted work. No external or internal funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UCLA IRB reviewed a request for exemption and granted this exemption.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referred to in the manuscript can be made available by request at the discretion of the authors.(AOR)Adjusted odds ratio(COVID-19)Coronavirus disease 2019(CSTE)Council of State and Territorial Epidemiologists(GEE)Generalized estimating equations(IFR)Infection fatality ratio(NPI)Non-pharmaceutical intervention(PCR)Polymerase chain reaction(SARS)Severe acute respiratory syndrome(SARS-CoV-2)Severe acute respiratory syndrome coronavirus 2